These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25669899)

  • 21. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
    Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
    Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
    Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential metabolic secretion between muscular dystrophy mouse-derived spindle cell sarcomas and rhabdomyosarcomas drives tumor type development.
    Niba ETE; Awano H; Nishimura N; Koide H; Matsuo M; Shinohara M
    Am J Physiol Cell Physiol; 2024 Jul; 327(1):C34-C47. PubMed ID: 38646787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
    Veltrop M; van Vliet L; Hulsker M; Claassens J; Brouwers C; Breukel C; van der Kaa J; Linssen MM; den Dunnen JT; Verbeek S; Aartsma-Rus A; van Putten M
    PLoS One; 2018; 13(2):e0193289. PubMed ID: 29466448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.
    Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R
    Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.
    Aranmolate A; Tse N; Colognato H
    BMC Neurosci; 2017 Aug; 18(1):63. PubMed ID: 28806929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L; Łukasiewicz K; Matryba P; Pikula S
    Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development.
    Vulin A; Wein N; Simmons TR; Rutherford AM; Findlay AR; Yurkoski JA; Kaminoh Y; Flanigan KM
    Neuromuscul Disord; 2015 Nov; 25(11):827-34. PubMed ID: 26365037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.
    Wang B; Li J; Xiao X
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13714-9. PubMed ID: 11095710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Compartment, Early Disruption of cGMP and cAMP Signalling in Cardiac Myocytes from the
    Brescia M; Chao YC; Koschinski A; Tomek J; Zaccolo M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
    Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
    Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.
    Hiller M; Spitali P; Datson N; Aartsma-Rus A
    Methods Mol Biol; 2018; 1828():249-262. PubMed ID: 30171546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor axonopathies in a mouse model of Duchenne muscular dystrophy.
    Dhindsa JS; McCall AL; Strickland LM; Fusco AF; Kahn AF; ElMallah MK
    Sci Rep; 2020 Jun; 10(1):8967. PubMed ID: 32488044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.